Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patients’ characteristics at baseline and 6 months after treatment with intragastric balloon (IGB)

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

  Baseline (n = 50) 6 months (n = 39) p value
BDI 16 (1–32) 6 (0–45) 0.0019
HADS-depression 7 (1–14) 4 (0–18) 0.0345
HADS-anxiety 8 (1–18) 5 (0–20) 0.0066
  1. These results refer only to patients who completed the study
  2. Data Median (minimum–maximum)
  3. BDI Beck Depression Inventory; HADS hospital anxiety and depression scale
Back to article page